These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 25456001)

  • 1. Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees.
    Yusuf HR; Hooper WC; Grosse SD; Parker CS; Boulet SL; Ortel TL
    Thromb Res; 2015 Jan; 135(1):50-7. PubMed ID: 25456001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of venous thromboembolism among hospitalizations of adults with selected autoimmune diseases.
    Yusuf HR; Hooper WC; Beckman MG; Zhang QC; Tsai J; Ortel TL
    J Thromb Thrombolysis; 2014 Oct; 38(3):306-13. PubMed ID: 24464552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infection.
    Chiao EY; Engels EA; Kramer JR; Pietz K; Henderson L; Giordano TP; Landgren O
    Arch Intern Med; 2009 Feb; 169(4):357-63. PubMed ID: 19237719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study.
    Zhu FX; Huang JY; Ye Z; Wen QQ; Wei JC
    Ann Rheum Dis; 2020 Jun; 79(6):793-799. PubMed ID: 32241798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Receiving Tofacitinib Versus Those Receiving Tumor Necrosis Factor Inhibitors: An Observational Cohort Study.
    Desai RJ; Pawar A; Weinblatt ME; Kim SC
    Arthritis Rheumatol; 2019 Jun; 71(6):892-900. PubMed ID: 30552833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization.
    Holmqvist ME; Neovius M; Eriksson J; Mantel Ä; Wållberg-Jonsson S; Jacobsson LT; Askling J
    JAMA; 2012 Oct; 308(13):1350-6. PubMed ID: 23032551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of venous thromboembolism in patients with rheumatoid arthritis.
    Kim SC; Schneeweiss S; Liu J; Solomon DH
    Arthritis Care Res (Hoboken); 2013 Oct; 65(10):1600-7. PubMed ID: 23666917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of venous thromboembolism in autoimmune diseases: A comprehensive review.
    Menichelli D; Cormaci VM; Marucci S; Franchino G; Del Sole F; Capozza A; Fallarino A; Valeriani E; Violi F; Pignatelli P; Pastori D
    Autoimmun Rev; 2023 Nov; 22(11):103447. PubMed ID: 37714419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
    Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
    J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of risk factors on the occurrence of arterial thrombosis and venous thromboembolism in adults with primary immune thrombocytopenia - Results from two nationwide cohorts.
    Ekstrand C; Linder M; Baricault B; Lafaurie M; Sailler L; Lapeyre-Mestre M; Kieler H; Moulis G; Bahmanyar S
    Thromb Res; 2019 Jun; 178():124-131. PubMed ID: 31026663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined autoimmune cytopenias.
    Martino R; Muñiz-Díaz E; Arilla M; Ibáñez M; Altés A; Guanyabens C; Madoz P
    Haematologica; 1995; 80(4):305-10. PubMed ID: 7590498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term incidence, risk factors and complications for venous thromboembolism in patients with systemic lupus erythematosus.
    Nossent JC; Keen HI; Preen DB; Inderjeeth CA
    Lupus; 2024 Jul; 33(8):787-796. PubMed ID: 38655753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous lupus erythematosus and the risk of deep venous thrombosis and pulmonary embolism: A Danish nationwide cohort study.
    Ahlehoff O; Wu JJ; Raunsø J; Kristensen SL; Khalid U; Kofoed K; Gislason G
    Lupus; 2017 Nov; 26(13):1435-1439. PubMed ID: 28618892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune hemolytic anemia and venous thromboembolism: A systematic review and meta-analysis.
    Ungprasert P; Tanratana P; Srivali N
    Thromb Res; 2015 Nov; 136(5):1013-7. PubMed ID: 26359320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Venous Thromboembolic Events in Pregnant Patients With Autoimmune Diseases: A Population-Based Study.
    Bleau N; Patenaude V; Abenhaim HA
    Clin Appl Thromb Hemost; 2016 Apr; 22(3):285-91. PubMed ID: 25294635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenectomy in systemic lupus erythematosus and autoimmune hematologic disease: a comparative analysis.
    Barron N; Arenas-Osuna J; Medina G; Cruz-Dominguez MP; González-Romero F; Velásques-García JA; Ayala-López EA; Jara LJ
    Clin Rheumatol; 2018 Apr; 37(4):943-948. PubMed ID: 29335897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of venous thromboembolism in patients with multiple sclerosis: the Clinical Practice Research Datalink.
    Peeters PJ; Bazelier MT; Uitdehaag BM; Leufkens HG; De Bruin ML; de Vries F
    J Thromb Haemost; 2014 Apr; 12(4):444-51. PubMed ID: 24502649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
    Shanafelt TD; Madueme HL; Wolf RC; Tefferi A
    Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults.
    Serris A; Amoura Z; Canouï-Poitrine F; Terrier B; Hachulla E; Costedoat-Chalumeau N; Papo T; Lambotte O; Saadoun D; Hié M; Blanche P; Lioger B; Gottenberg JE; Godeau B; Michel M
    Am J Hematol; 2018 Mar; 93(3):424-429. PubMed ID: 29247540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep disorders and increased risk of autoimmune diseases in individuals without sleep apnea.
    Hsiao YH; Chen YT; Tseng CM; Wu LA; Lin WC; Su VY; Perng DW; Chang SC; Chen YM; Chen TJ; Lee YC; Chou KT
    Sleep; 2015 Apr; 38(4):581-6. PubMed ID: 25669189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.